Stay updated on Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0, while the study record history remains unchanged.
    Difference
    0.1%
    Check dated 2026-10-31T18:07:07.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    A notice was added announcing NIH’s terminology transition from “Artificial Intelligence” to “Super Intelligence” and linking to related updates and FAQs.
    Difference
    0.4%
    Check dated 2026-10-24T20:22:39.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site’s revision label changed from v3.7.1 to v3.7.2.
    Difference
    0.1%
    Check dated 2026-10-17T21:00:29.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The ClinicalTrials.gov footer revision label changes from v3.7.0 to v3.7.1.
    Difference
    0.1%
    Check dated 2026-10-10T21:51:18.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    The record history now includes a new revision entry v3.7.0 and removes the previous v3.6.6 entry. This updates the revision timeline shown on the page.
    Difference
    0.1%
    Check dated 2026-09-19T20:35:35.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The study record history now displays the latest revision as v3.6.6, replacing the previous v3.6.5 and indicating a new version of the record history.
    Difference
    0.1%
    Check dated 2026-08-29T05:44:56.000Z thumbnail image

Stay in the know with updates to Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elotuzumab Combinations in Relapsed Multiple Myeloma Clinical Trial page.